O Bakke

Author PubWeight™ 57.42‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Post-replicative base excision repair in replication foci. EMBO J 1999 2.86
2 Targeting of membrane proteins to endosomes and lysosomes. Trends Cell Biol 1994 2.38
3 The Norwegian naturalistic treatment study of depression in general practice (NORDEP)-I: randomised double blind study. BMJ 1999 2.25
4 Cell surface HLA-DR-invariant chain complexes are targeted to endosomes by rapid internalization. Proc Natl Acad Sci U S A 1993 1.92
5 Antigen presentation mediated by recycling of surface HLA-DR molecules. Nature 1995 1.85
6 The MHC class II-associated invariant chain contains two endosomal targeting signals within its cytoplasmic tail. J Cell Sci 1993 1.69
7 Intracellular transport and localization of major histocompatibility complex class II molecules and associated invariant chain. J Cell Biol 1991 1.68
8 Glucocorticoids suppress the production of tumour necrosis factor by lipopolysaccharide-stimulated human monocytes. Immunology 1988 1.66
9 Relationship between invariant chain expression and major histocompatibility complex class II transport into early and late endocytic compartments. J Exp Med 1993 1.56
10 Mitotic partitioning of endosomes and lysosomes. Curr Biol 2001 1.38
11 Cell cycle characteristics of synchronized and asynchronous populations of human cells and effect of cooling of selected mitotic cells. Cell Tissue Kinet 1977 1.37
12 Nuclear and mitochondrial forms of human uracil-DNA glycosylase are encoded by the same gene. Nucleic Acids Res 1993 1.35
13 Stable surface expression of invariant chain prevents peptide presentation by HLA-DR. EMBO J 1992 1.33
14 The leucine-based sorting motifs in the cytoplasmic domain of the invariant chain are recognized by the clathrin adaptors AP1 and AP2 and their medium chains. J Biol Chem 1999 1.26
15 An LI and ML motif in the cytoplasmic tail of the MHC-associated invariant chain mediate rapid internalization. J Cell Sci 1994 1.24
16 Medium chains of adaptor complexes AP-1 and AP-2 recognize leucine-based sorting signals from the invariant chain. J Biol Chem 1998 1.20
17 Intracellular localization of the glucocorticoid receptor: evidence for cytoplasmic and nuclear localization. Endocrinology 1987 1.20
18 MHC II and the endocytic pathway: regulation by invariant chain. Scand J Immunol 2009 1.09
19 Toll-like receptor 2 (P631H) mutant impairs membrane internalization and is a dominant negative allele. Scand J Immunol 2010 1.04
20 A region from the medium chain adaptor subunit (mu) recognizes leucine- and tyrosine-based sorting signals. J Biol Chem 1998 0.99
21 Physiological functions of endosomal proteolysis. Biochem J 1995 0.97
22 A critical tyrosine residue in the cytoplasmic tail is important for CD1d internalization but not for its basolateral sorting in MDCK cells. J Immunol 1999 0.95
23 Intracellular distribution of the MHC class II molecules and the associated invariant chain (Ii) in different cell lines. Int Immunol 1993 0.93
24 Sorting of MHC class II molecules and the associated invariant chain (Ii) in polarized MDCK cells. J Cell Sci 1997 0.93
25 A flow cytometric and immunofluorescence microscopic study of tumor necrosis factor production and localization in human monocytes. Cell Immunol 1989 0.92
26 Culture characterization of differentiated high endothelial venule cells from human tonsils. Lab Invest 1999 0.91
27 Structure-activity relationship of the leucine-based sorting motifs in the cytosolic tail of the major histocompatibility complex-associated invariant chain. J Biol Chem 1995 0.91
28 A change in the oxygen effect throughout the cell-cycle of human cells of the line NHIK 3025 cultivated in vitro. Int J Radiat Biol Relat Stud Phys Chem Med 1977 0.87
29 The invariant chain inhibits presentation of endogenous antigens by a human fibroblast cell line. Eur J Immunol 1994 0.86
30 Exon 6 is essential for invariant chain trimerization and induction of large endosomal structures. J Biol Chem 1997 0.86
31 Invariant chain induces a delayed transport from early to late endosomes. J Biol Chem 1995 0.85
32 Targeting major histocompatibility complex class II molecules to the cell surface by invariant chain allows antigen presentation upon recycling. Eur J Immunol 1994 0.85
33 Antagonistic effect of glucocorticoids on retinoic acid induced growth inhibition and morphological alterations of a human cell line. Cancer Res 1986 0.84
34 MHC class II-associated invariant chain-induced enlarged endosomal structures: a morphological study. Exp Cell Res 1997 0.84
35 The leucine-based motif DDQxxLI is recognized both for internalization and basolateral sorting of invariant chain in MDCK cells. Eur J Cell Biol 1998 0.83
36 DR/CLIP (class II-associated invariant chain peptides) and DR/peptide complexes colocalize in prelysosomes in human B lymphoblastoid cells. J Immunol 1998 0.83
37 Concentration-dependent effects of potassium dichromate on the cell cycle. Cytometry 1984 0.82
38 Cell cycle-specific glucocorticoid growth regulation of a human cell line (NHIK 3025). J Cell Physiol 1981 0.82
39 The cytoplasmic tail of CD1d contains two overlapping basolateral sorting signals. J Biol Chem 2000 0.81
40 T-lymphocytes and the subpopulations of T-helper and T-suppressor cells measured by monoclonal antibodies (T11, T4, and T8) in relation to surgery under epidural and general anaesthesia. Acta Anaesthesiol Scand 1984 0.79
41 Human monocyte-released cytotoxic factor. Modulation of cytotoxic activity by inhibitors of cellular DNA, RNA, and protein synthesis. Scand J Immunol 1985 0.79
42 Overexpression of proteins containing tyrosine- or leucine-based sorting signals affects transferrin receptor trafficking. J Biol Chem 1999 0.78
43 Polarized transport of MHC class II molecules in Madin-Darby canine kidney cells is directed by a leucine-based signal in the cytoplasmic tail of the beta-chain. J Immunol 1999 0.78
44 Characterization and sequence-specific binding to mouse mammary tumor virus DNA of purified activated human glucocorticoid receptor. Biochemistry 1987 0.78
45 A new triple-stranded alpha-helical bundle in solution: the assembling of the cytosolic tail of MHC-associated invariant chain. Structure 1997 0.78
46 Major histocompatibility complex class II-dependent antigen presentation by human intestinal endothelial cells. Gastroenterology 1998 0.78
47 Intracellular transport of molecules engaged in the presentation of exogenous antigens. Curr Top Microbiol Immunol 1998 0.77
48 A fast and accurate method for calculating Engelberg's synchronization index. Cell Tissue Kinet 1976 0.77
49 Common peptide epitope in mumps virus nucleocapsid protein and MHC class II-associated invariant chain. Scand J Immunol 1993 0.77
50 Selection of phage displayed peptides from a random 10-mer library recognising a peptide target. Immunotechnology 1998 0.77
51 The MHC class II-associated chicken invariant chain shares functional properties with its mammalian homologs. Exp Cell Res 2000 0.76
52 The bio-logical role of invariant chain (Ii) in MHC class II antigen presentation. Immunol Lett 1994 0.76
53 Glucocorticoid mechanism of action: monoclonal antibodies as experimental tools. Med Oncol Tumor Pharmacother 1986 0.76
54 [Terror against the free world--politics and the Norwegian Medical Society]. Tidsskr Nor Laegeforen 2001 0.75
55 Structure requirements for glucocorticoid growth of a human cell line (NHIK 3025). J Steroid Biochem 1982 0.75
56 Cell-mediated inhibition of proliferation and activation of alloreactive cytotoxic lymphocytes: maintenance of response potential of precursors and dissociation between proliferation and effector function of activated cytotoxic lymphocytes. Cell Immunol 1986 0.75
57 Effects of potassium dichromate on the cell cycle of an established human cell line (NHIK 3025). Toxicology 1982 0.75
58 Effect of oral high-dose progestins on the disposition of antipyrine, digitoxin, and warfarin in patients with advanced breast cancer. Cancer Chemother Pharmacol 1986 0.75
59 The role of protein metabolism in glucocorticoid-induced prolongation of G1 phase in human NHIK 3025 cells. J Cell Physiol 1982 0.75
60 Soluble cytostatic factor(s) released from human monocytes. II. Effects on target cell kinetics. Scand J Immunol 1983 0.75
61 [Data technics in information systems. Promises and threats]. Tidsskr Nor Laegeforen 1977 0.75
62 Inhibition of in vitro lysozyme release from human granulocytes and monocytes by non-steroidal anti-inflammatory agents. Acta Pathol Microbiol Immunol Scand C 1987 0.75
63 [Talusin (proscillaridin)--once more]. Tidsskr Nor Laegeforen 1971 0.75
64 Clinical experience with depot neuroleptics. Acta Psychiatr Scand Suppl 1973 0.75